AUBREY HANDLEY: Open Payments
NPI 1427551555 · VALPARAISO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$248 in 14 payments from 7 companies in 2025. Trend: 2023 $1,367 · 2024 $348 · 2025 $248
Food & beverage: $248
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $64 |
| Indivior Inc. | 3 | $57 |
| ABBVIE INC. | 2 | $36 |
| Braeburn Inc. | 2 | $31 |
| Abbott Laboratories | 1 | $24 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: RELISTOR, SUBLOCADE, VRAYLAR, BRIXADI, PROCLAIM, Belbuca, REXULTI.
Industry payments across IN — which companies pay providers there.
